Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease.
Mpro
Nsp5
SARS-CoV-2
TRMT1
tRNA
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
20 Jul 2023
20 Jul 2023
Historique:
pubmed:
28
7
2023
medline:
28
7
2023
entrez:
28
7
2023
Statut:
epublish
Résumé
Nonstructural protein 5 (Nsp5) is the main protease of SARS-CoV-2 that cleaves viral polyproteins into individual polypeptides necessary for viral replication. Here, we show that Nsp5 binds and cleaves human tRNA methyltransferase 1 (TRMT1), a host enzyme required for a prevalent post-transcriptional modification in tRNAs. Human cells infected with SARS-CoV-2 exhibit a decrease in TRMT1 protein levels and TRMT1-catalyzed tRNA modifications, consistent with TRMT1 cleavage and inactivation by Nsp5. Nsp5 cleaves TRMT1 at a specific position that matches the consensus sequence of SARS-CoV-2 polyprotein cleavage sites, and a single mutation within the sequence inhibits Nsp5-dependent proteolysis of TRMT1. The TRMT1 cleavage fragments exhibit altered RNA binding activity and are unable to rescue tRNA modification in TRMT1-deficient human cells. Compared to wildtype human cells, TRMT1-deficient human cells infected with SARS-CoV-2 exhibit reduced levels of intracellular viral RNA. These findings provide evidence that Nsp5-dependent cleavage of TRMT1 and perturbation of tRNA modification patterns contribute to the cellular pathogenesis of SARS-CoV-2 infection.
Identifiants
pubmed: 37502865
doi: 10.1101/2023.02.10.527147
pmc: PMC10370084
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI050698
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI127370
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI150698
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM068411
Pays : United States
Déclaration de conflit d'intérêts
Competing Interest Statement: The authors declare no competing interests.